[Prospects for therapy and prevention of adenovirus keratoconjunctivitis].
Sundmacher
R
R
Universitäts-Augenklinik, Moorenstrasse 5, 40225 Düsseldorf.
Hillenkamp
J
J
Reinhard
T
T
D000258:Adenovirus Infections, Human / Q000175:diagnosis / Q000188:drug therapy / Q000517:prevention & control; D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000627:therapeutic use; D000328:Adult; D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D000077404:Cidofovir; D016572:Cyclosporine / Q000008:administration & dosage / Q000627:therapeutic use; D003596:Cytosine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use; D007372:Interferons / Q000008:administration & dosage / Q000627:therapeutic use; D007634:Keratitis / Q000175:diagnosis / Q000188:drug therapy / Q000517:prevention & control; D007639:Keratoconjunctivitis, Infectious / Q000175:diagnosis / Q000188:drug therapy / Q000517:prevention & control; D009883:Ophthalmic Solutions; D063065:Organophosphonates; D009943:Organophosphorus Compounds / Q000008:administration & dosage / Q000627:therapeutic use; D012008:Recurrence; D013997:Time Factors
D000305:Adrenal Cortex Hormones; D000998:Antiviral Agents; D007166:Immunosuppressive Agents; D009883:Ophthalmic Solutions; D063065:Organophosphonates; D009943:Organophosphorus Compounds; D016572:Cyclosporine; D003596:Cytosine; D007372:Interferons; D000077404:Cidofovir